Establishment of an Intradermal Ear Injection Model of IL-17A and IL-36γ as a Tool to Investigate the Psoriatic Cytokine Network.
IL-17A
IL-36γ
ear injection
mouse model
psoriasis
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
19 Aug 2021
19 Aug 2021
Historique:
received:
31
05
2021
revised:
28
07
2021
accepted:
16
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Psoriasis is a chronic skin disease affecting 2-3% of the global population. The proinflammatory IL-17A is a key cytokine in psoriasis. Accumulating evidence has revealed that IL-36γ plays also a pathogenic role. To understand more precisely the role of the IL-17A-IL-36γ cytokine network in skin pathology, we used an ear injection model. We injected IL-17A or IL-36γ alone and in combination into the ear pinnae of mice. This resulted in a significant increase in ear thickness measured over time. Histological evaluation of IL-17A + IL-36γ-treated skin showed a strong acanthosis, hyperparakeratosis and infiltration of neutrophils. The same histological features were found in mice after injection of IL-36γ alone, but to a lesser extent. IL-17A alone was not able to induce psoriasis-like changes. Genes encoding proteins of the S100 family, antimicrobial peptides and chemo-attractants for neutrophils were upregulated in the IL-17A + IL-36γ group. A much weaker expression was seen after the injection of each cytokine alone. These results strengthen the hypothesis that IL-17A and IL-36γ drive psoriatic inflammation via a synergistic interaction. Our established intradermal ear injection model can be utilized in the future to monitor effects of various inhibitors of this cytokine network.
Identifiants
pubmed: 34440590
pii: life11080846
doi: 10.3390/life11080846
pmc: PMC8402141
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Biochem Biophys Res Commun. 2012 Jul 13;423(4):647-53
pubmed: 22683330
J Invest Dermatol. 2008 May;128(5):1207-11
pubmed: 18200064
J Dermatol Sci. 2017 Sep;87(3):221-227
pubmed: 28633806
N Engl J Med. 2011 Aug 18;365(7):620-8
pubmed: 21848462
Trends Immunol. 2017 May;38(5):310-322
pubmed: 28254169
Nat Rev Rheumatol. 2015 Jul;11(7):415-29
pubmed: 25907700
Exp Dermatol. 2019 Mar;28(3):233-239
pubmed: 30614571
J Leukoc Biol. 2020 Jul;108(1):267-281
pubmed: 32421901
J Immunol. 2011 Feb 15;186(4):2613-22
pubmed: 21242515
Front Immunol. 2018 Jun 11;9:1298
pubmed: 29942307
Nucleic Acids Res. 2013 Apr;41(8):4378-91
pubmed: 23444143
Front Immunol. 2018 Feb 26;9:200
pubmed: 29535706
Curr Opin Rheumatol. 2017 Mar;29(2):208-213
pubmed: 27926540
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Br J Dermatol. 2001 Jun;144(6):1114-20
pubmed: 11422029
Nat Rev Immunol. 2014 Sep;14(9):585-600
pubmed: 25145755
Nat Immunol. 2010 Nov;11(11):973
pubmed: 20959797
Curr Protoc Immunol. 2019 Jun;125(1):e71
pubmed: 30615272
J Invest Dermatol. 1999 Nov;113(5):752-9
pubmed: 10571730
PLoS One. 2014 Oct 03;9(10):e108553
pubmed: 25279834
Br J Pharmacol. 2010 Feb;159(4):842-55
pubmed: 20050849
BMC Genomics. 2015 Jul 01;16:487
pubmed: 26126663
J Exp Med. 2007 Oct 29;204(11):2603-14
pubmed: 17908936
Adv Med Sci. 2015 Sep;60(2):349-54
pubmed: 26318079
J Exp Med. 2006 Nov 27;203(12):2577-87
pubmed: 17074928
Acta Naturae. 2013 Oct;5(4):110-7
pubmed: 24455190
Dermatol Ther. 2020 Jan;33(1):e13170
pubmed: 31762153
Int J Mol Sci. 2019 Jul 05;20(13):
pubmed: 31284527
J Immunol. 2018 Sep 15;201(6):1605-1613
pubmed: 30181299
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Invest Dermatol. 2000 May;114(5):976-83
pubmed: 10771480
J Eur Acad Dermatol Venereol. 2019 Feb;33(2):367-375
pubmed: 30357932
J Am Acad Dermatol. 2017 Mar;76(3):405-417
pubmed: 28057360
Int J Exp Pathol. 2009 Jun;90(3):232-48
pubmed: 19563608
Sci Signal. 2017 Sep 12;10(496):
pubmed: 28900043
N Engl J Med. 2019 Mar 7;380(10):981-983
pubmed: 30855749
Healthcare (Basel). 2021 May 07;9(5):
pubmed: 34066917
Lancet. 2021 Feb 20;397(10275):754-766
pubmed: 33515492
Eur J Immunol. 2013 Dec;43(12):3138-46
pubmed: 24254490
Lancet. 2018 Aug 25;392(10148):650-661
pubmed: 30097359
Curr Opin Rheumatol. 2016 May;28(3):204-10
pubmed: 27022911
J Invest Dermatol. 2015 Apr;135(4):1025-1032
pubmed: 25525775
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Sci Rep. 2017 Nov 15;7(1):15631
pubmed: 29142248
J Immunol. 2008 Oct 1;181(7):4733-41
pubmed: 18802076
Acta Derm Venereol. 1979;59(5):441-5
pubmed: 93368
Nature. 2007 Feb 8;445(7128):648-51
pubmed: 17187052
J Invest Dermatol. 2017 Nov;137(11):2380-2388
pubmed: 28634035
Cell Death Dis. 2018 Mar 7;9(3):378
pubmed: 29515113
Exp Dermatol. 2019 Feb;28(2):113-120
pubmed: 30417427
J Immunol. 2011 Feb 1;186(3):1495-502
pubmed: 21172868
Curr Opin Pharmacol. 2012 Aug;12(4):486-90
pubmed: 22398321
JCI Insight. 2019 Jan 24;4(2):
pubmed: 30674716
J Exp Med. 2004 Jan 5;199(1):125-30
pubmed: 14707118
Sci Transl Med. 2017 Oct 11;9(411):
pubmed: 29021166
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2658-68
pubmed: 25341795